Loading viewer...
investor_presentation
Format: PDF investor_presentation
Halozyme presents its June 2024 investor update covering financial guidance through 2028, ENHANZE® drug delivery technology patent developments, and collaboration expansion plans. The presentation outlines expectations for revenue growth, adjusted EBITDA margins, and royalty revenues from partner commercialization efforts.
investor_presentation
26 Pages
investor_presentation
28 Pages
CapitaLand Integrated Commercial Trust
Graphic Packaging International Investor Presentation — June 2021
investor_presentationinvestor_presentation
11 Pages
Graphic Packaging International, LLC